Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study

BACKGROUND: Due to safety signals after vaccination with COVID-19 vector vaccines, several states recommended to complete the primary immunization series in individuals having received one dose of ChAdOx1 (AstraZeneca) with an mRNA vaccine. However, data on safety and reactogenicity of this heterolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Warkentin, Lisette, Zeschick, Nikoletta, Kühlein, Thomas, Steininger, Philipp, Überla, Klaus, Kaiser, Isabelle, Gall, Christine, Sebastião, Maria, Hueber, Susann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152311/
https://www.ncbi.nlm.nih.gov/pubmed/35641934
http://dx.doi.org/10.1186/s12879-022-07443-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152311/
https://www.ncbi.nlm.nih.gov/pubmed/35641934
http://dx.doi.org/10.1186/s12879-022-07443-x

Ejemplares similares